Boston Scientific said on Thursday it will buy Penumbra in a deal valued at about $14.5 billion to expand its vascular pipeline. The deal values Penumbra at $374 per share, a premium of about 19.3% to ...
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2026-01-15 04:13:41















